Obbligazioni TKPHF
Di seguito è riportato l'elenco delle obbligazioni societarie Takeda Pharmaceutical Co., Ltd.. Gli investitori spesso optano per le obbligazioni di una società per la loro maggiore stabilità in tempi di volatilità del mercato. Studia i prezzi, i rendimenti e altre statistiche per trovare un investimento affidabile.
Simbolo | YTM % | Volume | Prezzo % | Cedola % | Data di maturazione | Importo in eccesso | Valore nominale | Importo min. denominazione | Emittente |
|---|---|---|---|---|---|---|---|---|---|
 TKPH5841810Takeda Pharmaceutical Company Limited 5.8% 05-JUL-2064 | 5,70% | 4,59 M | 101,49% | 5,80% | 2064-07-05 | 500 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5841809Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2054 | 5,57% | 3,33 M | 101,05% | 5,65% | 2054-07-05 | 600 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010048Takeda Pharmaceutical Company Limited 3.375% 09-JUL-2060 | 5,54% | 7,6 M | 66,70% | 3,38% | 2060-07-09 | 1 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010047Takeda Pharmaceutical Company Limited 3.175% 09-JUL-2050 | 5,53% | 1,59 M | 68,32% | 3,18% | 2050-07-09 | 2 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 5,47% | 622 K | 97,30% | 5,25% | 2045-06-23 | 500,41 M USD | 1.000,00 USD | 2.000,00 USD | Baxalta, Inc. |
| TKPH5841808Takeda Pharmaceutical Company Limited 5.65% 05-JUL-2044 | 5,40% | 2,83 M | 102,89% | 5,65% | 2044-07-05 | 800 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010046Takeda Pharmaceutical Company Limited 3.025% 09-JUL-2040 | 5,26% | 1,65 M | 77,12% | 3,03% | 2040-07-09 | 1,5 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5841807Takeda Pharmaceutical Company Limited 5.3% 05-JUL-2034 | 4,75% | 5,5 M | 103,93% | 5,30% | 2034-07-05 | 1,1 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| TKPH5010045Takeda Pharmaceutical Company Limited 2.05% 31-MAR-2030 | 4,20% | 1,13 M | 91,20% | 2,05% | 2030-03-31 | 2,5 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| UUS82481LAD1Shire Acquisitions Investments Ireland Designated Activity Company 3.2% 23-SEP-2026 | 4,19% | 0 | 99,01% | 3,20% | 2026-09-23 | 1,5 B USD | 1.000,00 USD | 2.000,00 USD | Shire Acquisitions Investments Ireland DAC |
| TKDBTakeda Pharmaceutical Company Limited 2.0% 09-JUL-2040 | 4,17% | 0 | 76,33% | 2,00% | 2040-07-09 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| TKPH4770188Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | 4,14% | 280 K | 102,49% | 5,00% | 2028-11-26 | 1,73 B USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| XS219734964Takeda Pharmaceutical Company Limited 1.375% 09-JUL-2032 | 3,37% | 0 | 88,00% | 1,38% | 2032-07-09 | 1 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS184344939Takeda Pharmaceutical Company Limited 3.0% 21-NOV-2030 | 3,15% | 0 | 99,25% | 3,00% | 2030-11-21 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS219734859Takeda Pharmaceutical Company Limited 1.0% 09-JUL-2029 | 2,96% | 0 | 93,03% | 1,00% | 2029-07-09 | 850 M EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| TKPH4770186Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | 2,89% | 0 | 116,57% | 5,00% | 2028-11-26 | 22,68 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |
| XS219734832Takeda Pharmaceutical Company Limited 0.75% 09-JUL-2027 | 2,70% | 0 | 96,61% | 0,75% | 2027-07-09 | 750 M EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| XS184344912Takeda Pharmaceutical Company Limited 2.25% 21-NOV-2026 | 2,31% | 0 | 99,91% | 2,25% | 2026-11-21 | 1,5 B EUR | 1.000,00 EUR | 100.000,00 EUR | Takeda Pharmaceutical Co., Ltd. |
| TKPH4770187Takeda Pharmaceutical Company Limited 5.0% 26-NOV-2028 | — | — | — | 5,00% | 2028-11-26 | 22,68 M USD | 1.000,00 USD | 200.000,00 USD | Takeda Pharmaceutical Co., Ltd. |